BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3983908)

  • 1. Treatment with stanozolol before thrombolysis in patients with arterial occlusions.
    Noll G; Lämmle B; Duckert F
    Thromb Res; 1985 Feb; 37(4):529-32. PubMed ID: 3983908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of oral stanozolol on fibrinolysis in type 2 diabetes mellitus.
    Small M; Lowe GD; MacCuish AC; Forbes CD
    Thromb Res; 1986 Oct; 44(2):253-9. PubMed ID: 3787569
    [No Abstract]   [Full Text] [Related]  

  • 3. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic effects of stanozolol in elderly medical patients.
    Small M; MacLean JA; McArdle BM; Bertina RM; Lowe GD; Forbes CD
    Thromb Res; 1984 Aug; 35(3):353-8. PubMed ID: 6547787
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
    Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
    Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind randomized trial of perioperative fibrinolytic enhancement for femoropopliteal bypass.
    Berridge DC; Frier M; Westby JC; Hopkinson BR; Makin GS
    Br J Surg; 1991 Jan; 78(1):101-4. PubMed ID: 1998848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombolytic therapy of acute peripheral arterial occlusions of limb arteries].
    Bucek J; Staffa R; Vojtísek B
    Rozhl Chir; 2011 Sep; 90(9):512-6. PubMed ID: 22320115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-enhanced Thrombolysis.
    Motarjeme A
    J Endovasc Ther; 2007 Apr; 14(2):251-6. PubMed ID: 17484537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment of subacute and acute synthetic and venous bypass-graft occlusions with percutaneous mechanical thrombectomy and thrombolysis.
    Hundt W; Kalinowski M; Stamm AC; Portig I; Swaid Z; Dietz C; Geks J; Burbelko M
    Eur J Radiol; 2013 Dec; 82(12):e807-15. PubMed ID: 24012453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic enhancement by stanozolol: a double blind trial.
    Davidson JF; Lochhead M; McDonald GA; McNicol GP
    Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?].
    Fiessinger JN; Aiach M; Vitoux JF; Pernes JM; Roncato M; Gaux JC
    Haemostasis; 1986; 16 Suppl 4():87-9. PubMed ID: 3770561
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultrasound-accelerated thrombolysis in arterial and venous peripheral occlusions: fibrinogen level effects.
    Raabe RD
    J Vasc Interv Radiol; 2010 Aug; 21(8):1165-72. PubMed ID: 20656221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intramuscular stanozolol on fibrinolysis and blood lipids.
    Small M; McArdle BM; Lowe GD; Forbes CD; Prentice CR
    Thromb Res; 1982 Oct; 28(1):27-36. PubMed ID: 6891506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen].
    Roncato M; Vitoux JF; Pernes JM; Aiach M; Fiessinger JN; Gaux JC; Housset E; Leclerc M
    Ann Biol Clin (Paris); 1985; 43(6):851-5. PubMed ID: 3832977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic enhancement with stanozolol fails to improve symptoms and signs in patients with post-surgical back pain.
    Cooper RG; Mitchell WS; Illingworth KJ; Jayson MI
    Scand J Rheumatol; 1991; 20(6):414-8. PubMed ID: 1837614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraarterial fibrinolysis: in vitro and prospective clinical evaluation of three thrombolytic agents.
    Pilger E; Lammer J; Bertuch H; Steiner H
    Radiology; 1986 Dec; 161(3):597-9. PubMed ID: 3786705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of Rt-pa thrombolysis combined with PGE1 in patients with peripheral arterial occlusions.
    Kröger K; Buss C; Rudofsky G
    Angiology; 2000 May; 51(5):377-84. PubMed ID: 10826854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Raynaud's phenomenon by fibrinolytic enhancement.
    Jarrett PE; Morland M; Browse NL
    Br Med J; 1978 Aug; 2(6136):523-5. PubMed ID: 698554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a peptide inhibitor of the glycoprotein IIb/IIIa platelet receptor: initial experience in patients with acute peripheral arterial occlusions.
    Yoon HC; Miller FJ
    AJR Am J Roentgenol; 2002 Mar; 178(3):617-22. PubMed ID: 11856686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.